Celltrion Pharm Inc (068760) — Cash Flow Quality Index
Celltrion Pharm Inc (068760) has a Cash Flow Quality Index of 2.05x as of September 2025. Operating cash flow of ₩23.44 Billion exceeds net income of ₩11.46 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Celltrion Pharm Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Celltrion Pharm Inc Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Celltrion Pharm Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Celltrion Pharm Inc.
Annual Cash Flow Quality Index for Celltrion Pharm Inc (2014–2024)
Year-by-year earnings quality comparison for Celltrion Pharm Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.58x | ₩56.59 Billion | ₩21.97 Billion | ▲ +525.6% |
| 2023 | 0.41x | ₩8.76 Billion | ₩21.26 Billion | ▲ +364.2% |
| 2022 | -0.16x | ₩-4.05 Billion | ₩25.96 Billion | ▼ -105.8% |
| 2021 | 2.69x | ₩93.15 Billion | ₩34.58 Billion | ▲ +55.6% |
| 2020 | 1.73x | ₩36.25 Billion | ₩20.94 Billion | ▼ -46.5% |
| 2019 | 3.24x | ₩27.85 Billion | ₩8.60 Billion | ▲ +162.1% |
| 2016 | -5.22x | ₩-15.21 Billion | ₩2.92 Billion | ▼ -362.9% |
| 2015 | 1.98x | ₩13.36 Billion | ₩6.73 Billion | ▼ -32.8% |
| 2014 | 2.95x | ₩17.33 Billion | ₩5.87 Billion | — |